Martin N, Pavord ID. Bronchial thermoplasty for the treatment of asthma. Curr Allergy Asthma Rep. 9(1):88-95 (2009).

Kelley DG. Double trouble: depression and the injured worker. Prof Case Manag. 14(1):57-9 (2009).

Alger JR, Schaewe TJ, Lai TC, Frew AJ, Vespa PM, Etchepare M, Liebeskind DS, Saver JL, Kidwell SC. Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging. J Magn Reson Imaging. 29(1):52-64 (2009).

Bang OY, Saver JL, Liebeskind DS, Lee PH, Sheen SS, Yoon SR, Yun SW, Kim GM, Chung CS, Lee KH, Ovbiagele B. Age-distinct predictors of symptomatic cervicocephalic atherosclerosis. Cerebrovasc Dis. 27(1):13-21 (2009).

Liebeskind DS. Venous hemodynamics may enhance collateral perfusion and the fibrinolytic milieu in paradoxical embolism. Stroke. 40(2):e30-1 (2009).

Ovbiagele B, McNair N, Pineda S, Liebeskind DS, Ali LK, Saver JL. A care pathway to boost influenza vaccination rates among inpatients with acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 18(1):38-40 (2009).

Bang OY, Saver JL, Alger JR, Shah SH, Buck BH, Starkman S, Ovbiagele B, Liebeskind DS. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke. 40(2):454-61 (2009).

Bang OY, Ovbiagele B, Liebeskind DS, Restrepo L, Yoon SR, Saver JL. Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke. J Neurol. 256(4):591-9 (2009).

Hallevi H, Barreto AD, Liebeskind DS, Morales MM, Martin-Schild SB, Abraham AT, Gadia J, Saver JL, Grotta JC, Savitz SI. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke. 40(5):1780-5 (2009).

Bang OY, Saver JL, Liebeskind DS, Pineda S, Yun SW, Ovbiagele B. Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic group. J Neurol Sci. 2009 Apr 25; (2009).

Saver JL, Gornbein J, Grotta J, Liebeskind D, Lutsep H, Schwamm L, Scott P, Starkman S. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke. 40(7):2433-7 (2009).

Liebeskind DS. Reversing Stroke in the 2010s. Lessons From Desmoteplase In Acute ischemic Stroke-2 (DIAS-2). Stroke. 2009 Jul 16; (2009).

Alger JR, Schaewe TJ, Lai TC, Frew AJ, Vespa PM, Etchepare M, Liebeskind DS, Saver JL, Kidwell SC. Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging. J Magn Reson Imaging. 29(1):52-64 (2009).

Kidwell CS, Lees KR, Muir KW, Chen C, Davis SM, De Silva DA, Weir CJ, Starkman S, Alger JR, Saver JL. Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial. Stroke. 40(5):1704-9 (2009).

Bang OY, Saver JL, Liebeskind DS, Lee PH, Sheen SS, Yoon SR, Yun SW, Kim GM, Chung CS, Lee KH, Ovbiagele B. Age-distinct predictors of symptomatic cervicocephalic atherosclerosis. Cerebrovasc Dis. 27(1):13-21 (2009).

Josephson SA, Saver JL, Smith WS. Comparison of mechanical embolectomy and intraarterial thrombolysis in acute ischemic stroke within the MCA: MERCI and Multi MERCI compared to PROACT II. Neurocrit Care. 10(1):43-9 (2009).

Saver JL, Gornbein J. Treatment effects for which shift or binary analyses are advantageous in acute stroke trials. Neurology. 72(15):1310-5 (2009).

Ovbiagele B, McNair N, Pineda S, Liebeskind DS, Ali LK, Saver JL. A care pathway to boost influenza vaccination rates among inpatients with acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 18(1):38-40 (2009).

Bang OY, Saver JL, Alger JR, Shah SH, Buck BH, Starkman S, Ovbiagele B, Liebeskind DS. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke. 40(2):454-61 (2009).

Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator: A Science Advisory From the American Heart Association/American Stroke Association. Stroke. 40(8):2945-2948 (2009).

Buck BH, Starkman S, Eckstein M, Kidwell CS, Haines J, Huang R, Colby D, Saver JL. Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System. Stroke. 40(6):2027-30 (2009).

Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M. Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke. 40(7):2594-600 (2009).

Bang OY, Ovbiagele B, Liebeskind DS, Restrepo L, Yoon SR, Saver JL. Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke. J Neurol. 256(4):591-9 (2009).

Hallevi H, Barreto AD, Liebeskind DS, Morales MM, Martin-Schild SB, Abraham AT, Gadia J, Saver JL, Grotta JC, Savitz SI. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke. 40(5):1780-5 (2009).

Bang OY, Saver JL, Liebeskind DS, Pineda S, Yun SW, Ovbiagele B. Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic group. J Neurol Sci. 2009 Apr 25; (2009).

Lansberg MG, Schrooten M, Bluhmki E, Thijs VN, Saver JL. Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke. 40(6):2079-84 (2009).

Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 40(6):2276-93 (2009).

Summers D, Leonard A, Wentworth D, Saver JL, Simpson J, Spilker JA, Hock N, Miller E, Mitchell PH. Comprehensive Overview of Nursing and Interdisciplinary Care of the Acute Ischemic Stroke Patient: A Scientific Statement From the American Heart Association. Stroke. 40(8):2911-2944 (2009).

Saver JL, Gornbein J, Grotta J, Liebeskind D, Lutsep H, Schwamm L, Scott P, Starkman S. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke. 40(7):2433-7 (2009).

Kidwell CS, Lees KR, Muir KW, Chen C, Davis SM, De Silva DA, Weir CJ, Starkman S, Alger JR, Saver JL. Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial. Stroke. 40(5):1704-9 (2009).

Bang OY, Saver JL, Alger JR, Shah SH, Buck BH, Starkman S, Ovbiagele B, Liebeskind DS. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke. 40(2):454-61 (2009).

Buck BH, Starkman S, Eckstein M, Kidwell CS, Haines J, Huang R, Colby D, Saver JL. Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System. Stroke. 40(6):2027-30 (2009).

Saver JL, Gornbein J, Grotta J, Liebeskind D, Lutsep H, Schwamm L, Scott P, Starkman S. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke. 40(7):2433-7 (2009).

Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 277(1-2):103-8 (2009).

Bang OY, Saver JL, Liebeskind DS, Lee PH, Sheen SS, Yoon SR, Yun SW, Kim GM, Chung CS, Lee KH, Ovbiagele B. Age-distinct predictors of symptomatic cervicocephalic atherosclerosis. Cerebrovasc Dis. 27(1):13-21 (2009).

Sanossian N, Gatto NM, Ovbiagele B. Patterns of influenza vaccination among stroke survivors. Neuroepidemiology. 32(3):165-70 (2009).

Ovbiagele B, McNair N, Pineda S, Liebeskind DS, Ali LK, Saver JL. A care pathway to boost influenza vaccination rates among inpatients with acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 18(1):38-40 (2009).

Bang OY, Saver JL, Alger JR, Shah SH, Buck BH, Starkman S, Ovbiagele B, Liebeskind DS. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke. 40(2):454-61 (2009).

Ovbiagele B. Association of ankle-brachial index level with stroke. J Neurol Sci. 276(1-2):14-7 (2009).

Ling G, Ovbiagele B. Oral antiplatelet therapy in the secondary prevention of atherothrombotic events. Am J Cardiovasc Drugs. 9(3):197-209 (2009).

Bang OY, Ovbiagele B, Liebeskind DS, Restrepo L, Yoon SR, Saver JL. Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke. J Neurol. 256(4):591-9 (2009).

Yoon SR, Bang OY, Hong JM, Li WY, Lee PH, Ovbiagele B. Non-conventional risk factors were associated with infarct patterns in ischemic stroke. Clin Neurol Neurosurg. 111(2):134-9 (2009).

Bang OY, Saver JL, Liebeskind DS, Pineda S, Yun SW, Ovbiagele B. Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic group. J Neurol Sci. 2009 Apr 25; (2009).

Zurru MC, Alonzo C, Brescacin L, Romano M, Camera LA, Waisman G, Cristiano E, Ovbiagele B. Recent respiratory infection predicts atherothrombotic stroke: case-control study in a Buenos Aires healthcare system. Stroke. 40(6):1986-90 (2009).

Towfighi A, Ovbiagele B. The impact of body mass index on mortality after stroke. Stroke. 40(8):2704-8 (2009).

Bang OY, Ovbiagele B, Liebeskind DS, Restrepo L, Yoon SR, Saver JL. Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke. J Neurol. 256(4):591-9 (2009).

Ovbiagele B, McNair N, Pineda S, Liebeskind DS, Ali LK, Saver JL. A care pathway to boost influenza vaccination rates among inpatients with acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 18(1):38-40 (2009).

Suzuki S, Tateshima S, Jahan R, Duckwiler GR, Murayama Y, Gonzalez NR, Vinuela F. Endovascular treatment of middle cerebral artery aneurysms with detachable coils: angiographic and clinical outcomes in 115 consecutive patients. Neurosurgery. 64(5):876-88; discussion (2009).

Jahan R, Vinuela F. Treatment of acute ischemic stroke: intravenous and endovascular therapies. Expert Rev Cardiovasc Ther. 7(4):375-87 (2009).

Guglielmi G, Vinuela F, Duckwiler G, Jahan R, Cotroneo E, Gigli R. Endovascular treatment of 306 anterior communicating artery aneurysms: overall, perioperative results. J Neurosurg. 110(5):874-9 (2009).

Shi ZS, Loh Y, Duckwiler GR, Jahan R, Vinuela F. Balloon-assisted transarterial embolization of intracranial dural arteriovenous fistulas. J Neurosurg. 110(5):921-8 (2009).

Suzuki S, Tateshima S, Jahan R, Duckwiler GR, Murayama Y, Gonzalez NR, Vinuela F. Endovascular treatment of middle cerebral artery aneurysms with detachable coils: angiographic and clinical outcomes in 115 consecutive patients. Neurosurgery. 64(5):876-88; discussion (2009).

Guglielmi G, Vinuela F, Duckwiler G, Jahan R, Cotroneo E, Gigli R. Endovascular treatment of 306 anterior communicating artery aneurysms: overall, perioperative results. J Neurosurg. 110(5):874-9 (2009).

Shi ZS, Loh Y, Duckwiler GR, Jahan R, Vinuela F. Balloon-assisted transarterial embolization of intracranial dural arteriovenous fistulas. J Neurosurg. 110(5):921-8 (2009).

Suzuki S, Tateshima S, Jahan R, Duckwiler GR, Murayama Y, Gonzalez NR, Vinuela F. Endovascular treatment of middle cerebral artery aneurysms with detachable coils: angiographic and clinical outcomes in 115 consecutive patients. Neurosurgery. 64(5):876-88; discussion (2009).

Jahan R, Vinuela F. Treatment of acute ischemic stroke: intravenous and endovascular therapies. Expert Rev Cardiovasc Ther. 7(4):375-87 (2009).

Guglielmi G, Vinuela F, Duckwiler G, Jahan R, Cotroneo E, Gigli R. Endovascular treatment of 306 anterior communicating artery aneurysms: overall, perioperative results. J Neurosurg. 110(5):874-9 (2009).

Shi ZS, Loh Y, Duckwiler GR, Jahan R, Vinuela F. Balloon-assisted transarterial embolization of intracranial dural arteriovenous fistulas. J Neurosurg. 110(5):921-8 (2009).

Gonzalez NR. Commentary. Surg Neurol. 71(1):24 (2009).

Suzuki S, Tateshima S, Jahan R, Duckwiler GR, Murayama Y, Gonzalez NR, Vinuela F. Endovascular treatment of middle cerebral artery aneurysms with detachable coils: angiographic and clinical outcomes in 115 consecutive patients. Neurosurgery. 64(5):876-88; discussion (2009).

Suzuki S, Tateshima S, Jahan R, Duckwiler GR, Murayama Y, Gonzalez NR, Vinuela F. Endovascular treatment of middle cerebral artery aneurysms with detachable coils: angiographic and clinical outcomes in 115 consecutive patients. Neurosurgery. 64(5):876-88; discussion (2009).

Alger JR, Schaewe TJ, Lai TC, Frew AJ, Vespa PM, Etchepare M, Liebeskind DS, Saver JL, Kidwell SC. Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging. J Magn Reson Imaging. 29(1):52-64 (2009).

Vespa PM. Metabolic penumbra in intracerebral hemorrhage. Stroke. 40(5):1547-8 (2009).

Mazziotta JC, Woods R, Iacoboni M, Sicotte N, Yaden K, Tran M, Bean C, Kaplan J, Toga AW. The myth of the normal, average human brain-The ICBM experience: (1) Subject screening and eligibility. Neuroimage. 44(3):914-922 (2009).

Mazziotta JC, Woods R, Iacoboni M, Sicotte N, Yaden K, Tran M, Bean C, Kaplan J, Toga AW. The myth of the normal, average human brain--the ICBM experience: (1) subject screening and eligibility. Neuroimage. 44(3):914-22 (2009).

Oishi K, Faria A, Jiang H, Li X, Akhter K, Zhang J, Hsu JT, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Woods R, Toga AW, Pike GB, Rosa-Neto P, Evans A, Mazziotta J, Mori S. Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage. 46(2):486-99 (2009).

Alger JR, Schaewe TJ, Lai TC, Frew AJ, Vespa PM, Etchepare M, Liebeskind DS, Saver JL, Kidwell SC. Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging. J Magn Reson Imaging. 29(1):52-64 (2009).

Kidwell CS, Lees KR, Muir KW, Chen C, Davis SM, De Silva DA, Weir CJ, Starkman S, Alger JR, Saver JL. Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial. Stroke. 40(5):1704-9 (2009).

Bang OY, Saver JL, Alger JR, Shah SH, Buck BH, Starkman S, Ovbiagele B, Liebeskind DS. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke. 40(2):454-61 (2009).